2013
Use of a Computerized Order Set to Increase Prescription of Calcium and Vitamin D Supplementation in Patients Receiving Glucocorticoids
Kohler MJ, Amezaga M, Drozd J, Crowley ST, Gulanski B, Anderson DR, Fraenkel L. Use of a Computerized Order Set to Increase Prescription of Calcium and Vitamin D Supplementation in Patients Receiving Glucocorticoids. Journal Of General Internal Medicine 2013, 28: 825-829. PMID: 23404201, PMCID: PMC3663954, DOI: 10.1007/s11606-013-2360-1.Peer-Reviewed Original ResearchConceptsVitamin D supplementationD supplementationVitamin DGlucocorticoid prescriptionComputerized ordersSingle VA medical centerOrder setsPrescription of calciumVitamin D prescriptionVitamin D supplementsGlucocorticoid-induced osteopeniaNumber of patientsKey ResultsA totalNumber of prescriptionsVA Medical CenterBackgroundAmerican CollegeGlucocorticoid useRheumatology guidelinesD supplementsResultsA totalMain MeasuresWeNumber of calciumPatientsA totalMedical CenterPatients
2006
Patient treatment preferences for osteoporosis
Fraenkel L, Gulanski B, Wittink D. Patient treatment preferences for osteoporosis. Arthritis & Rheumatism 2006, 55: 729-735. PMID: 17013870, PMCID: PMC1626097, DOI: 10.1002/art.22229.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAgedAged, 80 and overBone Density Conservation AgentsCross-Sectional StudiesDiphosphonatesDose-Response Relationship, DrugFemaleFractures, BoneHealth Care SurveysHumansInfusions, IntravenousInjections, SubcutaneousMaleMiddle AgedOsteoporosisParathyroid HormonePatient CompliancePatient SatisfactionRecombinant ProteinsRisk AssessmentSurveys and QuestionnairesConceptsPreferred treatment optionRoute of administrationPatient's preferred treatment optionRecombinant human parathyroid hormoneOsteoporosis treatment optionsTreatment optionsAnnual infusionPatient preferencesTreatment preferencesIntravenous bisphosphonatesTreatment choiceRisk of vertebralTreatment-naive participantsPatients' treatment preferencesLong-term adherenceIndividual patient preferencesHuman parathyroid hormoneOral bisphosphonatesOsteoporosis medicationsWeekly bisphosphonatesWeekly pillConjoint analysis questionnaireOral medicationsHip fractureFuture fracturesPatient willingness to take teriparatide
Fraenkel L, Gulanski B, Wittink D. Patient willingness to take teriparatide. Patient Education And Counseling 2006, 65: 237-244. PMID: 16965888, PMCID: PMC1769517, DOI: 10.1016/j.pec.2006.08.004.Peer-Reviewed Original ResearchMeSH KeywordsAbsorptiometry, PhotonAdministration, OralAgedAged, 80 and overBone Density Conservation AgentsChoice BehaviorConnecticutDrug Administration ScheduleFemaleFractures, BoneHealth Knowledge, Attitudes, PracticeHealth Services Needs and DemandHumansInjections, SubcutaneousMiddle AgedMultivariate AnalysisOsteoporosis, PostmenopausalPatient Acceptance of Health CarePostmenopauseRisk AssessmentSocioeconomic FactorsSurveys and QuestionnairesTeriparatideWomenConceptsDaily subcutaneous injectionsTreatment preferencesSubcutaneous injectionFuture fracturesMost womenAbsolute fracture riskTreatment of osteoporosisNovel treatment approachesConjoint analysis questionnairePostmenopausal womenAdaptive conjoint analysis questionnaireDaily injectionsPoor adherenceEfficacy advantageFracture riskPatients' willingnessClinical studiesAge 71Bone densitometryEffective treatmentNumber of subjectsTreatment approachesT-scoreOlder adultsWomen